in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Carbogen Amcis Partners with ADC Biotechnology
8:07 AM MDT | September 25, 2012 | Deepti Ramesh
Carbogen Amcis (Bubendorf, Switzerland), a pharma process-development and active pharmaceutical ingredient (API) manufacturing subsidiary of Dishman Pharmaceuticals and Chemicals (Ahmedabad, India) says it has entered into a collaboration with ADC Biotechnology (ADC Bio; Denbighshire, U.K.) to provide customers with seamless development and manufacturing services for antibody-drug conjugates (ADCs)—a key anticancer treatment platform. The alliance will offer a range of services to customers for the development, scale-up, manufacturing, and formulation...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee